Sometimes we have a window of opportunity to make a difference. In this series we discuss time-frames where lithium, clozapine, and metformin have the greatest benefits.

CME: Take the CME Post-Test for this Episode

Published On: 02/17/2025

Duration: 19 minutes, 28 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Sometimes we have a window of opportunity to make a difference. Here, we discuss time-frames where lithium, clozapine, and metformin have the greatest benefits.

CME: Take the CME Post-Test for this Episode

Published On: 02/10/2025

Duration: 17 minutes, 23 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Learn how your patient’s life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.

CME: Take the CME Post-Test for this Episode

Published On: 02/03/2025

Duration: 16 minutes, 41 seconds

Chris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Learn how an understanding of patient’s temperament and the meaning of their life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.

CME: Take the CME Post-Test for this Episode

Published On: 01/27/2025

Duration: 18 minutes, 12 seconds

Chris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Margaret Chisolm shares the Perspectives model, a way of assessing patients that builds on the DSM takes the famous manual a few steps further.

CME: Take the CME Post-Test for this Episode

Published On: 01/20/2025

Duration: 22 minutes, 23 seconds

Chris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.

CME: Take the CME Post-Test for this Episode

Published On: 01/13/2025

Duration: 07 minutes, 41 seconds

Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shares his approach to chronic depression.

CME: Take the CME Post-Test for this Episode

Published On: 01/06/2025

Duration: 16 minutes, 47 seconds

Chris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shares his approach to chronic depression.

CME: Take the CME Post-Test for this Episode

Published On: 12/30/2024

Duration: 16 minutes, 45 seconds

Chris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shows us how to put the common ingredients of effective therapy into practice at every visit.

CME: Take the CME Post-Test for this Episode

Published On: 12/23/2024

Duration: 16 minutes, 53 seconds

Chris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shows us how to adjust our therapeutic approach for problems that are simple and those a bit more complex.

CME: Take the CME Post-Test for this Episode

Published On: 12/16/2024

Duration: 21 minutes, 45 seconds

Chris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.